Variable | Sample | Control | Study | ||
Total | <37 GW | >37 GW | |||
IL-6 (ng/ml) | Sample 1 | 4.97 ± 1.68 | 10.37 ± 2.2 | 10.95 ± 2.93 | 10.1 ± 1.8 |
P value | P1 < 0.0001 | P3 = 0.256 | |||
Sample 2 | 7.2 ± 2.6 | 6.71 ± 1.7 | 8.72 ± 0.9 | 5.82 ± 1.1 | |
P value | P1 = 0.326 | P3 = 0.0001 | |||
P2 < 0.0001 | P2 < 0.0001 | P2 = 0.007 | P2 < 0.0001 | ||
Change in relation to S1 level | Increase by 140% (IQR: 131 - 151) | Decrease by 32.6% (IQR: 19 - 46) | Decrease by 16% (IQR: 7 - 26) | Decrease by 37.2% (IQR: 32 - 50) | |
P value | P1 < 0.0001 | P3 = 0.0001 | |||
TNF-α (ng/ml) | Sample 1 | 0.82 ± 0.19 | 1.44 ± 0.5 | 2.08 ± 0.3 | 1.15 ± 0.22 |
P value | P1 < 0.0001 | P1 < 0.0001 | |||
Sample 2 | 0.98 ± 0.26 | 1.11 ± 0.45 | 1.68 ± 0.29 | 0.86 ± 0.23 | |
P value | P1 = 0.117 | P1 < 0.0001 | |||
P2 = 0.0008 | P2 = 0.001 | P2 = 0.001 | P2 < 0.0001 | ||
Change in relation to S1 level | Increase by 114% (IQR: 110 - 129) | Decrease by 19% (IQR: 17 - 31) | Decrease by 18% (IQR: 14 - 21) | Decrease by 21% (IQR: 17 - 32) | |
P value | P1 < 0.0001 | P1 = 0.041 | |||
IL-10 (ng/ml) | Sample 1 | 0.96 ± 0.25 | 1.98 ± 0.6 | 2.63 ± 0.34 | 1.69 ± 0.43 |
P value | P1 < 0.0001 | P1 < 0.0001 | |||
Sample 2 | 1.25 ± 0.33 | 1.13 ± 0.6 | 1.96 ± 0.32 | 0.75 ± 0.15 | |
P value | P1 = 0.255 | P1 < 0.0001 | |||
P2 < 0.0001 | P2 < 0.0001 | P2 < 0.0001 | P2 < 0.0001 | ||
Change in relation to S1 level | Increase by 129% (IQR: 115 - 141) | Decrease by 44% (IQR: 35 - 57) | Decrease by 31% (IQR: 16 - 35) | Decrease by 51% (IQR: 42 - 65) | |
P value | P1 < 0.0001 | P1 < 0.0001 |